Literature DB >> 18804703

Mitochondrial methylenetetrahydrofolate dehydrogenase, methenyltetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetases.

Karen E Christensen1, Robert E Mackenzie.   

Abstract

Folate-mediated metabolism involves enzyme-catalyzed reactions that occur in the cytoplasmic, mitochondrial, and nuclear compartments in mammalian cells. Which of the folate-dependent enzymes are expressed in these compartments depends on the stage of development, cell type, cell cycle, and whether or not the cell is transformed. Mitochondria become formate-generating organelles in cells and tissues expressing the MTHFD2 and MTHFD1L genes. The products of these nuclear genes were derived from trifunctional precursor proteins, expressing methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase activities. The MTHFD2 protein is a bifunctional protein with dehydrogenase and cyclohydrolase activities that arose from a trifunctional precursor through the loss of the synthetase domain and a novel adaptation to NAD rather than NADP specificity for the dehydrogenase. The MTHFD1L protein retains the size of its trifunctional precursor, but through the mutation of critical residues, both the dehydrogenase and cyclohydrolase activities have been silenced. MTHFD1L is thus a monofunctional formyltetrahydrofolate synthetase. This review discusses the properties and functions of these mitochondrial proteins and their role in supporting cytosolic purine synthesis during embryonic development and in cells undergoing rapid growth.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804703     DOI: 10.1016/S0083-6729(08)00414-7

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  29 in total

1.  Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.

Authors:  Susan K Murphy; Hyuna Yang; Cynthia A Moylan; Herbert Pang; Andrew Dellinger; Manal F Abdelmalek; Melanie E Garrett; Allison Ashley-Koch; Ayako Suzuki; Hans L Tillmann; Michael A Hauser; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2013-07-31       Impact factor: 22.682

2.  Mitochondrial Methylenetetrahydrofolate Dehydrogenase (MTHFD2) Overexpression Is Associated with Tumor Cell Proliferation and Is a Novel Target for Drug Development.

Authors:  Philip M Tedeschi; Alexei Vazquez; John E Kerrigan; Joseph R Bertino
Journal:  Mol Cancer Res       Date:  2015-06-22       Impact factor: 5.852

3.  MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells.

Authors:  S Duygu Selcuklu; Mark T A Donoghue; Kristina Rehmet; Matheus de Souza Gomes; Antoine Fort; Prasad Kovvuru; Mohan K Muniyappa; Michael J Kerin; Anton J Enright; Charles Spillane
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

4.  Engineering the Reductive Glycine Pathway: A Promising Synthetic Metabolism Approach for C1-Assimilation.

Authors:  Nico J Claassens; Ari Satanowski; Viswanada R Bysani; Beau Dronsella; Enrico Orsi; Vittorio Rainaldi; Suzan Yilmaz; Sebastian Wenk; Steffen N Lindner
Journal:  Adv Biochem Eng Biotechnol       Date:  2022       Impact factor: 2.635

5.  Methylene tetrahydrofolate dehydrogenase/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major.

Authors:  Silvane M F Murta; Tim J Vickers; David A Scott; Stephen M Beverley
Journal:  Mol Microbiol       Date:  2009-01-16       Impact factor: 3.501

6.  Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice.

Authors:  Jessica Momb; Jordan P Lewandowski; Joshua D Bryant; Rebecca Fitch; Deborah R Surman; Steven A Vokes; Dean R Appling
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

Review 7.  A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight.

Authors:  Christine R Cuthbertson; Zahra Arabzada; Armand Bankhead; Armita Kyani; Nouri Neamati
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-01

8.  High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.

Authors:  Laura Lehtinen; Kirsi Ketola; Rami Mäkelä; John-Patrick Mpindi; Miro Viitala; Olli Kallioniemi; Kristiina Iljin
Journal:  Oncotarget       Date:  2013-01

9.  Remobilization of Tol2 transposons in Xenopus tropicalis.

Authors:  Donald A Yergeau; Clair M Kelley; Emin Kuliyev; Haiqing Zhu; Amy K Sater; Dan E Wells; Paul E Mead
Journal:  BMC Dev Biol       Date:  2010-01-22       Impact factor: 1.978

Review 10.  Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.

Authors:  Aamod S Dekhne; Zhanjun Hou; Aleem Gangjee; Larry H Matherly
Journal:  Mol Cancer Ther       Date:  2020-09-02       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.